Drug profile · INN
pasireotide embonate
SIGNIFOR LAR
pasireotide embonate (SIGNIFOR LAR) is a somatostatin receptor 1 agonist. Associated with Recordati Rare Diseases Australia Pty..
TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — pasireotide embonate
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.81
Quick answer
pasireotide embonate (SIGNIFOR LAR) is a somatostatin receptor 1 agonist. Associated with Recordati Rare Diseases Australia Pty..
Key facts
INN pasireotide embonate
Brand SIGNIFOR LAR
Mechanism Somatostatin receptor 1 agonist
Target Somatostatin receptor type 1
Originator Recordati Rare Diseases Australia Pty.
Mechanism of action
Somatostatin receptor 1 agonist
Primary target: Somatostatin receptor type 1
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Related & competitor drugs
Frequently asked questions
What is pasireotide embonate?
pasireotide embonate (SIGNIFOR LAR) is a somatostatin receptor 1 agonist. Associated with Recordati Rare Diseases Australia Pty..
What is the brand name for pasireotide embonate?
SIGNIFOR LAR is a marketed brand name for pasireotide embonate. Check FDA Drugs@FDA for the current US label holder and prescribing information.